Q3 2018 EPS Estimates for Steris Plc Lowered by Analyst (STE)
Steris Plc (NYSE:STE) – Research analysts at Northcoast Research reduced their Q3 2018 earnings per share estimates for Steris Plc in a report released on Wednesday. Northcoast Research analyst D. Keiser now anticipates that the medical equipment provider will earn $1.10 per share for the quarter, down from their previous forecast of $1.11. Northcoast Research also issued estimates for Steris Plc’s Q4 2018 earnings at $1.18 EPS, Q1 2019 earnings at $0.95 EPS, Q3 2019 earnings at $1.21 EPS and Q4 2019 earnings at $1.29 EPS.
STE has been the topic of several other reports. Zacks Investment Research raised shares of Steris Plc from a “sell” rating to a “hold” rating in a report on Friday, June 23rd. KeyCorp raised shares of Steris Plc from a “sector weight” rating to an “overweight” rating and set a $89.00 price target on the stock in a report on Wednesday, May 3rd. BidaskClub cut shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a report on Monday, July 31st. Wellington Shields cut shares of Steris Plc from a “gradually accumulate” rating to a “hold” rating in a report on Monday, June 5th. Finally, Raymond James Financial, Inc. increased their price target on shares of Steris Plc from $90.00 to $95.00 and gave the company an “outperform” rating in a report on Wednesday. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. Steris Plc has an average rating of “Buy” and a consensus target price of $86.75.
Steris Plc (NYSE STE) traded down 0.887% during midday trading on Thursday, reaching $85.465. The company’s stock had a trading volume of 116,846 shares. The firm has a 50 day moving average price of $82.41 and a 200-day moving average price of $74.89. Steris Plc has a 52 week low of $63.80 and a 52 week high of $87.49. The firm has a market cap of $7.27 billion, a P/E ratio of 61.134 and a beta of 1.33.
Steris Plc (NYSE:STE) last released its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share for the quarter, beating analysts’ consensus estimates of $0.80 by $0.05. The company had revenue of $608 million for the quarter, compared to the consensus estimate of $597.66 million. Steris Plc had a return on equity of 11.39% and a net margin of 4.63%. The company’s quarterly revenue was down 4.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.79 earnings per share.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, September 28th. Shareholders of record on Tuesday, August 29th will be given a dividend of $0.31 per share. This represents a $1.24 dividend on an annualized basis and a dividend yield of 1.44%. The ex-dividend date of this dividend is Friday, August 25th. This is a positive change from Steris Plc’s previous quarterly dividend of $0.28. Steris Plc’s dividend payout ratio is presently 80.00%.
In other Steris Plc news, CEO Walter M. Rosebrough, Jr. sold 10,000 shares of the stock in a transaction that occurred on Friday, June 2nd. The shares were sold at an average price of $80.05, for a total transaction of $800,500.00. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, VP Sudhir K. Pahwa sold 800 shares of the stock in a transaction that occurred on Thursday, May 25th. The stock was sold at an average price of $77.28, for a total transaction of $61,824.00. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 30,340 shares of company stock worth $2,432,704. Company insiders own 2.55% of the company’s stock.
Several hedge funds and other institutional investors have recently made changes to their positions in the company. Alliancebernstein L.P. raised its position in shares of Steris Plc by 804.7% in the second quarter. Alliancebernstein L.P. now owns 52,571 shares of the medical equipment provider’s stock worth $4,285,000 after buying an additional 46,760 shares during the last quarter. Dearborn Partners LLC raised its position in shares of Steris Plc by 7.2% in the second quarter. Dearborn Partners LLC now owns 330,677 shares of the medical equipment provider’s stock worth $26,950,000 after buying an additional 22,302 shares during the last quarter. Los Angeles Capital Management & Equity Research Inc. acquired a new position in shares of Steris Plc during the second quarter worth about $746,000. JPMorgan Chase & Co. raised its position in shares of Steris Plc by 177.5% in the second quarter. JPMorgan Chase & Co. now owns 186,087 shares of the medical equipment provider’s stock worth $15,166,000 after buying an additional 119,035 shares during the last quarter. Finally, Sawtooth Solutions LLC raised its position in shares of Steris Plc by 1.3% in the second quarter. Sawtooth Solutions LLC now owns 4,232 shares of the medical equipment provider’s stock worth $345,000 after buying an additional 54 shares during the last quarter. Hedge funds and other institutional investors own 91.80% of the company’s stock.
Steris Plc Company Profile
STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.
Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with MarketBeat.com's FREE daily email newsletter.